Article 421: Singapore: Hub for Clinical Trials in Asia

• The clinical trials market in Singapore has doubled in size since the country adopted ICH-GCP in 1998. Bolstered by well-developed technology and hospital infrastructures, strict adherence to international standards, considerable investment by multinational pharmaceutical, biotech companies and CROs, and a well-educated English-speaking population, Singapore has become an attractive place to conduct clinical trials.

Article 422: Analysis: US Newspapers Fail to Report on Trial Risks, Benefits

• Thomson CenterWatch has recently completed a survey of how the top daily newspapers in the United States report on clinical trials and found that their reporting for the most part failed to discuss potential risks and benefits for patients.

Article 423: Education, Customization Key to BBK Recruitment in EU

• Patient recruitment is still in its infancy in most European countries, and BBK Healthcare of Newton, Mass. has been at the forefront of efforts in the EU.

Article 424: Eye on: Sexually Transmitted Diseases

• About 1.4 million adults in the U.S. have sexually transmitted diseases. CenterWatch has identified a pipeline of 39 drugs in development for sexually transmitted diseases.